Coordinating cancer clinical trials across the Parkville Precinct
The Parkville Cancer Clinical Trials Unit (PCCTU) is Australia’s largest cancer clinical trials unit, specialising in first in human, phase I, medical oncology, haematology, and palliative care clinical trials.
In August 2016, the Parkville Cancer Clinical Trials Unit (PCCTU) amalgamated the cancer clinical trials units of Peter MacCallum Cancer Centre, The Royal Melbourne Hospital and The Royal Women’s Hospital. The PCCTU is located in the purpose built Victorian Comprehensive Cancer Centre building in Parkville, Melbourne.
Internationally recognised Investigators with expertise and experience in:
- The conduct of cancer clinical trials
- Basic research, translational research and biomarker development
- Collaborations with national and international Investigators
- Novel clinical trial design
Ten multi-disciplinary research teams based on tumour stream.
A dedicated clinical trial treatment area and facilities.
Strategically located, PCCTU delivers a precinct service with premier results. This provides access to a comprehensive range of specialised medical services, for example:
- Shared pathology service
- Clinical trials pharmacy
- Intensive Care Unit
- Shared medical record
- Speciality clinics
- Translational expertise and leading edge laboratory service
To approach PCCTU with a potential clinical trial, email through:
- Mutual Confidentiality Agreement in editable word format (if required)
- Protocol or synopsis
- Number of sites
- Number of participants
To the Feasibility Coordinator and Tumour Stream lead per below stream profiles.
Business hours, Monday to Friday
Email [email protected]
Phone +61 3 8559 7350 or +61 3 8559 7958
PCCTU site profile is available through the Shared Investigator Platform (SIP).
Clinical Haematology is a unified department formed between Peter Mac and the Royal Melbourne Hospital and is the largest haematology service in the country, offering a broad clinical trials program.
The Clinical Haematology program offers a wide range of advanced research treatments for many of the Peter Mac and Royal Melbourne patients.
Acute Leukaemias and Myelodysplastic Syndromes
Hodgkin Lymphoma and Aggressive non-Hodgkin Lymphoma
Allogeneic Bone Marrow Transplant
Chronic Myeloid Leukaemia and Myeloproliferative Neoplasms
Indolent non-Hodgkin Lymphoma and T-cell Lymphoproliferative Disease
Late Effects and Survivorship
The Medical Oncology tumour streams delivers world-class cancer care, backed by an uncompromising commitment to research, clinical trials and evidence-based practice to ensure the best possible outcome for patients.
Medical Oncology Leads
Upper Gastro-Intestinal Cancers
Lower Gastro-Intestinal Cancers
Head and Neck and Cutaneous Squamous Cell Carcinoma
Melanoma and Skin Cancer
Professor Mark Rosenthal
Associate Professor Jayesh Desai
Ms Marian Lieschke
Phone +61 3 8559 7140
Ms Kylie Shackleton
Phone +61 3 8559 6205
Ms Maryanne Turner
Phone +61 3 8559 7350
Ms Safia Humam
Phone +61 3 8559 7958